An abstract representation of neural synapses
A speaker from Azadyne presenting to an audience at the FASEB RNA conference
September 1, 2022

Azadyne speaking at FASEB RNA conference

Great to see one of the Azadyne founders, Prof Vincent Kelly, of Trinity College Dublin speaking today on ‘RNA modification as a target for autoimmunity’ at FASEB meeting on “RNA associated mechanisms: In immunity and Disease”, in Steamboat, Colorado.

A close-up of various test tubes and chemical beakers
March 27, 2019

Azadyne Announce Funding Round

Azadyne, which is developing a new approach to the treatment of autoimmune diseases, announced that it has raised £1.5million (€1.75 million) in its most recent funding round.